Clinical data over long term with sitagliptin treatment for type 2 diabetes patients in our hospital

Clinical data over long term with sitagliptin treatment for type 2 diabetes patients in our hospital - Clinical data over long term with sitagliptin treatment for type 2 diabetes patients in our hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036793

Enrollment

300

Registered

2019-05-19

Start date

2018-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Outpatients 2) over 20 years old 3) T2DM 4) eGFR over 30 mL/min/1.73 m2 5) Diet and exercise therapies are well performed 6) Patients who are suspected good-compliant 7) Understanding of the study procedures and agreement to participate in the study, by giving written informed consent

Exclusion criteria

Exclusion criteria: 1) Patients suspected of having secondary diabetes (ex. endocrine disease, drug-induced or liver disease) 2) Females who are pregnant or who intend to become pregnant within the study 3) Severe hepatic disease, malignancy, a history of gastrectomy and/or positive for HIV 4) Contraindication with sitagliptin 5) Patient who disqualified from the study by the investigator for any reason other than given above.

Design outcomes

Primary

Measure	Time frame
HbA1c, Urinary albumin	—

Secondary

Measure	Time frame
1. Efficacy and safety of sitagliptin single use 2. Safety in the elderly 3. Safety of patients using insulin	—

Countries

Japan

Contacts

Public ContactYasuhiro Iijima

Manda Memorial Hospital Diabetes Center

yasuhiro.iijima1203@gmail.com011-231-4032

Outcome results